articleNature NanotechnologyApr 21, 2017Closed access

A STING-activating nanovaccine for cancer immunotherapy

The University of Texas Southwestern Medical Center · Howard Hughes Medical Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding